Medical Writing Review: Ensuring Accuracy and Compliance in Healthcare Content
Healthcare content has life-or-death accuracy requirements. Here's how to review patient-facing content, clinical documentation, pharma marketing, and health communications for accuracy and compliance.
Healthcare content carries stakes that other content doesn't. A misleading health claim can cause real harm. An inaccurate drug interaction warning can be fatal. A patient information leaflet written at grade 14 reading level excludes the 40-50% of adults with limited health literacy — the people who need clear health information most.
Medical writing review isn't about style preferences. It's about accuracy, appropriate certainty language, regulatory compliance, and accessibility. Every piece of healthcare content — from patient leaflets to pharmaceutical marketing to clinical trial reports — needs structured review against specific criteria before it reaches its audience.
The Healthcare Content Spectrum
Healthcare content spans a wide range of audiences, purposes, and regulatory requirements:
| Content Type | Audience | Key Requirement | Regulatory Context |
|---|---|---|---|
| Patient information leaflets | Patients, carers | Plain language (grade 6-8), accuracy | TGA, FDA, EMA requirements |
| Consumer health content | General public | No unsupported claims, balanced information | Advertising standards, health claims regulations |
| Healthcare professional content | Doctors, nurses, pharmacists | Clinical accuracy, evidence grading | Professional standards, journal requirements |
| Pharmaceutical marketing | HCPs and consumers | Fair balance, indication accuracy | TGA, FDA, ABPI/IFPMA codes |
| Clinical trial documentation | Regulators, ethics committees | Protocol adherence, completeness | ICH-GCP, regulatory submissions |
| Health policy documents | Policy makers, administrators | Evidence-based, clear recommendations | Government standards |
| Medical device documentation | Users, regulators | Safety information, usage instructions | TGA, FDA, CE marking requirements |
Each type has different quality criteria. A patient leaflet and a clinical trial report both need accuracy, but they need different levels of technical detail, different reading levels, and different regulatory compliance checks.
Review Criteria by Content Type
Patient-Facing Content
Patient content must be accurate AND accessible. The challenge is communicating complex medical information clearly without oversimplifying to the point of inaccuracy.
| Criterion | Weight | What to Check |
|---|---|---|
| Readability | 3 | Flesch-Kincaid grade 6-8, short sentences, defined medical terms |
| Accuracy | 3 | Claims supported by current clinical evidence, no misleading information |
| Balanced information | 2 | Benefits AND risks presented, not just positive outcomes |
| Actionability | 2 | Clear instructions for what the patient should DO |
| Appropriate certainty | 3 | Language matches evidence strength ("may help" vs "will cure") |
| Disclaimer presence | 1 | "Consult your healthcare provider" or equivalent included |
Common patient content failures:
| Failure | Example | Risk |
|---|---|---|
| Unsupported claims | "This supplement boosts immunity" | Misleading, potential regulatory action |
| Inappropriate certainty | "This treatment cures diabetes" | Dangerous misinformation |
| Too technical | "Exhibits antihypertensive properties via ACE inhibition" | Patient can't understand, can't act |
| Missing risks | Benefits described without side effects or contraindications | Incomplete informed consent |
| No action steps | Describes a condition without telling the patient what to do | Information without utility |
Healthcare Professional Content
HCP content can use technical language but must maintain clinical accuracy and evidence-based rigour.
| Criterion | Weight | What to Check |
|---|---|---|
| Clinical accuracy | 3 | Claims match current evidence, guidelines referenced correctly |
| Evidence grading | 3 | Level of evidence stated (RCT, meta-analysis, case report, expert opinion) |
| Citation quality | 2 | Primary sources cited, recent evidence prioritised, peer-reviewed sources |
| Balanced presentation | 2 | Limitations acknowledged, alternative approaches mentioned |
| Terminology accuracy | 2 | Medical terms used correctly, consistent with accepted nomenclature |
| Regulatory compliance | 1 | On-label claims only, off-label clearly identified |
Pharmaceutical Marketing
Pharma marketing is among the most heavily regulated content types. Fair balance, indication accuracy, and regulatory compliance are non-negotiable.
| Criterion | Weight | What to Check |
|---|---|---|
| Fair balance | 3 | Risks presented with equal prominence to benefits |
| Indication accuracy | 3 | Claims limited to approved indications |
| Reference substantiation | 3 | Every efficacy claim supported by referenced clinical data |
| Risk communication | 2 | Contraindications, warnings, and adverse events clearly stated |
| Regulatory compliance | 2 | Meets TGA/FDA/EMA advertising requirements |
| Audience appropriateness | 1 | HCP materials use appropriate language; consumer materials are accessible |
Clinical Documentation
Clinical trial protocols, reports, and regulatory submissions require completeness, precision, and adherence to reporting standards.
| Criterion | Weight | What to Check |
|---|---|---|
| Protocol adherence | 3 | Document follows the approved protocol structure |
| Reporting completeness | 3 | All required sections present per ICH-GCP or relevant guidelines |
| Statistical reporting | 2 | Results reported with appropriate statistical measures |
| Consistency | 2 | Data consistent across tables, figures, and text |
| Terminology | 2 | MedDRA coding used correctly, consistent terminology |
The Critical Issue: Certainty Language
The single most important quality criterion in healthcare content is certainty language — ensuring that the confidence expressed in claims matches the strength of the supporting evidence.
The Certainty Scale
| Evidence Strength | Appropriate Language | Inappropriate Language |
|---|---|---|
| Strong (multiple RCTs, meta-analyses) | "Evidence demonstrates," "has been shown to" | Still not "cures" or "guarantees" |
| Moderate (single RCT, large cohort studies) | "Evidence suggests," "may be effective" | "Proven to," "will definitely" |
| Limited (small studies, observational) | "Preliminary evidence indicates," "may contribute to" | "Is effective," "works for" |
| Emerging (case reports, in-vitro) | "Early research suggests," "warrants further investigation" | "Breakthrough," "game-changing" |
| Expert opinion (no direct evidence) | "Clinical experience suggests," "experts recommend" | "Evidence shows," "research proves" |
The rule: The language should never express more certainty than the evidence supports. "This supplement boosts immunity" requires strong evidence from multiple RCTs. "Preliminary research suggests this supplement may support immune function" is appropriate for limited evidence.
Building Healthcare Content Reviewers
Patient Information Reviewer
System prompt guidance:
Review this patient-facing healthcare content for:
1. Readability (target grade 6-8)
2. Accuracy of health claims
3. Appropriate certainty language (claims match evidence strength)
4. Balanced information (benefits AND risks/limitations)
5. Clear action steps for the patient
6. Disclaimer presence
Flag any health claims that express more certainty than the
evidence supports. Flag any content above grade 8 reading level.
Flag any missing risk information or action steps.
Knowledge base uploads:
- Clinical guidelines relevant to the topic
- Your organisation's health content style guide
- Regulatory requirements for your jurisdiction (TGA, FDA, etc.)
Pharmaceutical Marketing Reviewer
System prompt guidance:
Review this pharmaceutical marketing content for:
1. Fair balance (benefits and risks presented with equal prominence)
2. On-label claims only (limited to approved indications)
3. Every efficacy claim supported by referenced clinical data
4. Risk communication (contraindications, warnings, adverse events)
5. Regulatory compliance with [specify: TGA/FDA/EMA/ABPI code]
Flag any efficacy claim without a supporting reference.
Flag any claim that extends beyond approved indications.
Flag any risk information that's less prominent than benefit claims.
Clinical Documentation Reviewer
System prompt guidance:
Review this clinical document for:
1. Completeness against [specify reporting guideline: CONSORT/STROBE/PRISMA]
2. Consistency between text, tables, and figures
3. Statistical reporting accuracy
4. MedDRA terminology consistency
5. Protocol adherence
Flag any data inconsistencies between sections.
Flag any missing required sections per the reporting guideline.
Workflow for Healthcare Content Teams
For Marketing/Communications Teams
- Draft content with health claims identified
- First review: AI reviewer checks readability, certainty language, balanced information, and disclaimer presence
- Address flagged issues — adjust certainty language, add missing risk information, simplify reading level
- Clinical/medical review: Subject matter expert verifies clinical accuracy
- Regulatory review: Compliance team verifies against applicable regulations
- Final approval and publish
AI review handles steps 2-3 (language quality, structure, certainty). Human experts handle steps 4-5 (clinical accuracy, regulatory compliance). This sequence means the clinical reviewer sees cleaner content and can focus on accuracy rather than style.
For Medical Writing Teams
- Draft document following the appropriate reporting guideline
- First review: AI reviewer checks completeness against the guideline, internal consistency, and terminology
- Address structural issues before peer review
- Peer review: Another medical writer reviews for scientific accuracy
- Statistical review: Statistician verifies data and analysis reporting
- Final QC and submission
Important Limitations
AI content review for healthcare has specific limitations that must be acknowledged:
What AI Review Can Do
- Check readability level against targets
- Flag certainty language that may be too strong for the context
- Check for balanced presentation (benefits and risks)
- Verify structural completeness against reporting guidelines
- Check terminology consistency
- Flag missing disclaimers or risk information
What AI Review Cannot Do
- Verify clinical accuracy. AI cannot determine whether a medical claim is factually correct. A statement that "Drug X reduces blood pressure by 15mmHg" might be perfectly well-written but clinically inaccurate. Clinical accuracy verification requires a qualified medical professional.
- Interpret regulatory requirements. AI can check whether content follows a structural template, but it cannot determine whether content meets the specific regulatory requirements of your jurisdiction. Regulatory compliance requires qualified regulatory affairs professionals.
- Replace medical/legal/regulatory review (MLR). In pharmaceutical contexts, the MLR process is a regulatory requirement. AI review is a quality step that precedes MLR, not a substitute for it.
- Make clinical judgments. Whether a particular risk warrants inclusion, how to characterise a drug interaction, or what constitutes appropriate fair balance — these are clinical and regulatory judgments that require human expertise.
AI review makes the human review process more efficient by catching structural, language, and completeness issues first. It does not replace any required human review step.
Frequently Asked Questions
Can AI review replace medical/legal/regulatory (MLR) review?
No. MLR review is a regulatory requirement for pharmaceutical content in most jurisdictions. AI review is a pre-MLR quality step that catches language, structure, and completeness issues so that MLR reviewers can focus on clinical accuracy and regulatory compliance.
What readability level should patient content target?
Grade 6-8 (Flesch-Kincaid) for general patient content. Health literacy research consistently shows that lower reading levels improve comprehension and health outcomes. Even educated patients benefit from clear, simple health information — medical situations create cognitive load that reduces effective reading level.
How do I handle content that must use technical medical terms?
Define technical terms on first use in patient-facing content. In HCP content, use accepted medical nomenclature without definition. The key is matching terminology to the audience: "myocardial infarction" for HCPs, "heart attack" for patients (with the clinical term in parentheses if needed for medical records context).
Is this applicable to health and wellness content (non-clinical)?
Yes — health and wellness content often makes claims that require the same certainty language discipline. "This yoga practice reduces anxiety" requires evidence. "Many practitioners report that this yoga practice helps them manage stress" is more appropriately hedged for the evidence level.
How do I review content across multiple languages?
Configure separate reviewers for each language with language-specific readability targets and terminology glossaries. Medical terminology translation requires particular care — automated translation of medical content is a significant patient safety risk.
Key Takeaways
- Healthcare content has accuracy requirements that other content doesn't — inappropriate certainty language can cause real harm.
- Certainty language is the most critical review criterion — claims must match evidence strength.
- Different content types need different reviewers — patient leaflets, HCP content, pharma marketing, and clinical documentation each have distinct quality requirements.
- AI review handles language, structure, and completeness — clinical accuracy and regulatory compliance require qualified human professionals.
- Patient content should target grade 6-8 readability — health literacy gaps affect 40-50% of adults.
- AI review precedes, not replaces, clinical and regulatory review — it makes the human review process more efficient by catching quality issues first.
- Fair balance in pharmaceutical marketing is non-negotiable — benefits and risks must be presented with equal prominence.
This article is for informational purposes only. It does not constitute medical, pharmaceutical, or regulatory advice. Healthcare content must be reviewed by qualified medical professionals and regulatory affairs specialists. AI content review is a quality assurance tool that does not replace required clinical, legal, or regulatory review processes.